SEC 13F Intelligence

Lion Point Capital, LP / CUE1EUR

Lion Point Capital, LP’s Cue Biopharma Inc Position

Does Lion Point Capital, LP own Cue Biopharma Inc (CUE1EUR)? Yes2.20M shares worth $506,436 (+3.03% of its 13F portfolio) as of Q1 2026.

Position Value
$506,436
Q1 2026
Shares
2.20M
% of Portfolio
+3.03%
Quarters Held
2
currently held

Position History CUE1EUR

Reported value by quarter
Q4 ’25: $672,752Q4 ’25Q1 ’26: $506,436Q1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.20M$506,436+3.03%
Q4 20252.20M$672,752+3.48%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lion Point Capital, LP’s full portfolio or all institutional holders of CUE1EUR.